Aandeel A038070 SEOULIN BIOSCIENCE CO.,LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Seoulin Bioscience Co.,Ltd.

Aandelen

A038070

KR7038070009

slotkoers Korea S.E.
Andere beurzen
 00:00:00 03-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8.770 KRW +0,11% Intraday-grafiek van Seoulin Bioscience Co.,Ltd. +0,69% -4,67%
20/03 Seoulin Bioscience Co.,Ltd. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
2023 Seoulin Bioscience Co.,Ltd. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) dropped from S&P Global BMI Index
Light Farm Tech Co., Ltd. announced that it has received KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd.
Light Farm Tech Co., Ltd. announced that it expects to receive KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd. and other investors
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Seoulin Bioscience Co.,Ltd. announced that it has received KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) added to S&P Global BMI Index
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on June 11, 2019, has expired.
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on August 8, 2019, has expired with 92,246 shares, representing 1.2% for KRW 802.37 million.
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A038070
  4. Nieuws Seoulin Bioscience Co.,Ltd.
  5. Andere talen